Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07513337 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effects of Cannabis Species Labeling and Marketing on Perceptual, Subjective and Objective Use Outcomes (Aim 2 Study)

StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status changed: Enrolling by Invitation → Completed
    • Final enrollment: 3035 participants (planned 2000)
    • Primary and study completion dates changed from estimate of Aug 2026 to Jul 16, 2026
    • Eligibility criteria shortened, about 8 words
  2. Re-verified, no change to tracked fieldsv4
  3. Primary and study completion pushed from Jul 2026 to Aug 2026v3
  4. Trial status changed: Not Yet Recruiting → Enrolling by Invitation
    • Start date changed from estimate of May 2026 to Apr 15, 2026
    • Site contact updated
    • Collaborators expanded, about 6 words
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study looks at how cannabis product label and marketing claims affect product perceptions, use expectancies, and use intentions among inexperienced and experienced cannabis users. Participants will answer online survey questions on their perceptions of a cannabis product advertisement.
Trial Details
NCT Number NCT07513337
Lead Sponsor Johns Hopkins Bloomberg School of Public Health
Collaborators: National Institute on Drug Abuse (NIDA)
Conditions
(from sponsor)		 Cannabis Use
Enrollment 3,035 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov